NEW YORK CITY, NY / ACCESS Newswire / June 23, 2025 / Solar Communities, Inc. (NYSE: SUI)
Lifshitz Law PLLC pronounces investigation into doable securities legal guidelines violations and/or breaches of fiduciary duties in reference to allegations that the Firm made materially false and/or deceptive statements and/or did not disclose materials info. Particularly, the Firm supplied buyers with materials info regarding SUI’s accounting practices and inside management over monetary reporting. Allegedly, the Firm supplied overwhelmingly constructive statements to buyers whereas, on the identical time, disseminating materially false and deceptive statements and/or concealing materials opposed info regarding the place cash was coming from, particularly, undisclosed loans and a $4 million mortgage.
On September 24, 2024, after market shut, Blue Orca Capital revealed a report that the Firm’s CEO obtained an undisclosed $4 million mortgage from the household of a Firm Board member. As well as, the report discovered that the CEO borrowed cash from one other Board member. Blue Orca’s investigation concluded that the CEO and his undisclosed loans from purported impartial Board members tremendously “compromises the independence of the Board as a complete, the Compensation Committee and, critically, the Audit Committee.” It additionally raises “questions as to the integrity of the Firm’s governance, controls and monetary disclosures.” Following the report’s revelations, the Firm’s inventory value declined dramatically.
If you’re a SUI investor, and would really like extra details about our investigation, please full the Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
Pacira Biosciences, Inc. (NASDAQ: PCRX)
Lifshitz Law PLLC pronounces investigation into doable securities legal guidelines violations and/or breaches of fiduciary duties in reference to allegations that the Firm made materially false and/or deceptive statements and/or did not disclose materials info. Particularly, Pacira allegedly disseminated materially false and deceptive statements and/or hid materials opposed info in regards to the validity and scope of the Firm’s patents. On August 9, 2024, Pacira introduced that the New Jersey District Court docket had invalidated its ‘495 patent. This announcement shocked buyers and analysts alike as they reacted instantly to the revelations, and the worth of Pacira’s widespread inventory declined dramatically.
If you’re a PCRX investor, and would really like extra details about our investigation, please full the Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
ModivCare, Inc. (NASDAQ: MODV)
Lifshitz Law PLLC pronounces investigation into doable securities legal guidelines violations and/or breaches of fiduciary duties in reference to allegations that the Firm made materially false and/or deceptive statements and/or did not speak in confidence to buyers materials info. Particularly, sure contracts that the Firm utilized in its non-emergency medical transportation (“NEMT”) phase allegedly precipitated the Firm’s free money circulate to deteriorate and because of this, (i) contract renegotiations and pricing lodging negatively impacted the Firm’s adjusted EBITDA; (ii) the Firm had inadequate liquidity; and (iii) the Firm’s constructive statements about its enterprise, operations, and prospects have been materially deceptive and/or lacked an inexpensive foundation.
If you’re a MODV investor, and would really like extra details about our investigation, please full the Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
Integral Ad Science Holding Corp. (NASDAQ: IAS)
Lifshitz Law PLLC pronounces investigation into doable securities legal guidelines violations and/or breaches of fiduciary duties in reference to allegations that the Firm made materially false and/or deceptive statements and/or did not disclose materials info. Particularly, the Firm allegedly misrepresented and/or did not disclose (1) that IAS was experiencing a brand new materials pattern of elevated aggressive pricing pressures and that, because of this, IAS had been pressured to chop costs to compensate for weakening demand and slowing income development; (2) that IAS’s pricing operate was not “favorable” and IAS couldn’t maintain its pricing and drive value will increase; (3) that pricing had grow to be a key differentiator between IAS and its competitor needed to shut main renewals and new offers; (4) that the danger that competitors “may end in elevated pricing stress” or “may put stress on us to vary our costs” had in reality transpired; and (5) because of this, the Firm’s public statements have been materially false and deceptive.
If you’re an IAS investor, and would really like extra details about our investigation, please full the Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
ATTORNEY ADVERTISING.© 2025 Lifshitz Legislation PLLC. The legislation agency answerable for this commercial is Lifshitz Legislation PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior outcomes don’t assure or predict an analogous end result with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Legislation PLLC
Cellphone: 516-493-9780
Facsimile: 516-280-7376
E-mail: jlifshitz@lifshitzlaw.com
SOURCE: Lifshitz Legislation Agency
View the unique press release on ACCESS Newswire
